- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04115969
Outcome After Non-invasive Ventilation.
June 10, 2020 updated by: Jakob Wallden
Outcome After Non-invasive Ventilation - an Observational Study at the Intensive Care Unit at Sundsvall Hospital.
The study is an exploratory retrospective observational study with the aim to describe outcome fo the cohort of patients that receive non-invasive ventilation at an intensive care unit.
Main research questions are:
- Characteristics of the cohort.
- The course for the patients at the ICU.
- ICU-mortality and 30-day mortality
- Amount of patients with limitations of care.
- Factors associated with mortality.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
92
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
X
-
Sundsvall, X, Sweden, 851 86
- Västernorrland County Council / Sundsvall Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients admitted to Sundsvalls intensive care unit treated with non-invasive ventilation.
Description
Inclusion Criteria:
- Patients treated with Non invasive ventilation
- Admitted to Sundsvalls ICU during 2018
Exclusion Criteria:
- Below 18 years age.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients with non-invasive ventilation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient characteristics
Time Frame: At the day of admission to the ICU - 1 day
|
Age, gender, comorbidities, indications for respiratory support, BMI, limitations of care.
|
At the day of admission to the ICU - 1 day
|
ICU-mortality
Time Frame: Patients will be followed during their ICU-stay - estimated to be 1 to 60 days.
|
Death occuring during ICU stay
|
Patients will be followed during their ICU-stay - estimated to be 1 to 60 days.
|
30-day mortality
Time Frame: 30 days from admission to ICU
|
Death within 30 days after ICU admission
|
30 days from admission to ICU
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Factors associated with mortality
Time Frame: 30 days from admission to ICU
|
Evaluate patient and ICU-factors and relation to mortality.
|
30 days from admission to ICU
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erik Svensk, MD, Västernorrland county council (Region Västernorrland)
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 4, 2019
Primary Completion (Actual)
December 31, 2019
Study Completion (Actual)
December 31, 2019
Study Registration Dates
First Submitted
October 2, 2019
First Submitted That Met QC Criteria
October 3, 2019
First Posted (Actual)
October 4, 2019
Study Record Updates
Last Update Posted (Actual)
June 12, 2020
Last Update Submitted That Met QC Criteria
June 10, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIV-SUNDSVALL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Insufficiency
-
Hospital Israelita Albert EinsteinRecruitingRespiratory Insufficiency in ChildrenBrazil
-
Vyaire MedicalCompletedRespiratory Insufficiency in ChildrenUnited Kingdom, Poland, Netherlands
-
Vyaire MedicalCompletedRespiratory Insufficiency in ChildrenNetherlands, Poland
-
Shanghai 10th People's HospitalUnknownPatients With Respiratory InsufficiencyChina
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingRespiratory Insufficiency Requiring Mechanical VentilationChina
-
Erasme University HospitalCentre Hospitalier Régional de la CitadelleNot yet recruitingRespiratory Insufficiency Requiring Mechanical VentilationBelgium
-
Fondazione Salvatore MaugeriAzienda Ospedaliero, Universitaria Pisana; Ataturk Training and Research HospitalCompletedChronic Respiratory InsufficiencyItaly
-
ADIR AssociationSuspendedCOPD | Chronic Respiratory InsufficiencyFrance
-
University Hospital, BordeauxCompletedRespiratory Failure | Acute Respiratory InsufficiencyFrance
-
Yolanda Lopez FernandezHospital Infantil Universitario Niño Jesús, Madrid, Spain; Dr. Negrin University... and other collaboratorsRecruitingAcute Respiratory InsufficiencySpain